Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
20m
on MSN
Ozempic-like jab 'fails' for millions with condition, study finds
A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition ...
Armed robbery in Revesby
43m
GLP-1 Drug Offers Limited Aid for Parkinson's Patients
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Places global staff on leave
Suspends parcels from China
Arrested on multiple charges
Key Bridge design unveiled
Sued by former nanny
Offers to jail US criminals
Spiritual leader dies
Ohio warehouse shooting
Hyde announces retirement
FireAid raises over $100M
Adds surcharge to eggs
Plans to take over Gaza
Wins Senate committee vote
Confirmed as VA secretary
Neo-Nazi leader convicted
FBI agents sue DOJ
US begins migrant flights
Offers buyouts to workforce
To launch streaming service
Senate confirms Bondi as AG
Neil Jacobs to lead NOAA
To cut up to 7,000 jobs
Suspended 10 games
Announces death of mother
All 67 bodies recovered
RFK Jr. clears Senate panel
Atmospheric river slams CA
Mimics moon’s gravity
US job openings fall
Related topics
United States
New York
Onapgo
Supernus
GLP-1
Feedback